Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma
Clinical trial NCT00920907 · COMPLETED
Trial details
- NCT number
- NCT00920907
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-04-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.